About Modelio Equity
Modelio Equity is a venture capital firm founded in 2016. It is primarily based out of Stockholm, Sweden. As of Oct 2019, Modelio Equity has invested in 23 companies. It primarily invests in Conventional Debt round in Denmark based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and Gaming. Most recently it participated in the $***** Conventional Debt round of ExpreS2ion Biotechnologies Overall, Modelio Equity portfolio has seen 4 IPOs and 3 acquisitions including key companies like ExpreS2ion Biotechnologies, BROCC and Catenamedia. Modelio Equity has team of 5 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Rounds of Entry
Conventional Debt
Portfolio IPOs
Portfolio Acquisitions
Modelio Equity's List of Top Investments
Modelio Equity has a portfolio of 23 companies. Their most notable investments include Monivent and ExpreS2ion Biotechnologies.Their portfolio spans across Sweden, Denmark, Germany and 1 more locations. They have invested in Enterprise Applications, Life Sciences, Gaming and 16 other sectors, across stages such as Conventional Debt stage. Here is the list of top investments by Modelio Equity:1. Monivent
Monivent's Neo is a non-invasive monitoring device that is add-on to existing manual ventilation equipment, helping the caregiver ensure an effective and gentle treatment during manual ventilation of newborns who are unable to breathe spontaneously. The airflow given to the baby during the treatment is measured directly in the face mask through the integrated sensor module and the data is wirelessly transferred to the external monitoring unit. It also provides feedback on several critical parameters, such as tidal volume, for evaluation through an external display.
Key facts about Monivent
- Founded Year: 2013
- Location: Gothenburg (Sweden)
- Stage: Seed
- Total Funding till date: $424K
- Employee Count: 12 as on Aug 31, 2026
- Investors: Modelio Equity, Almi Invest and 3 Others
- Latest Funding Round: Seed, Nov 18, 2015, $*****
Provider of recombinant protein production using an insect expression platform. The platform technology uses a non-viral Drosophila cell expression platform for protein production. The ExpreS2 kit allows customers to set up the ExpreS2 platform in-house. ExpreS2ion Biotech also partners with companies for the development of vaccines for breast cancer, coronavirus, and tropical diseases, such as malaria and chikungunya.
Key facts about ExpreS2ion Biotechnologies
- Founded Year: 2010
- Location: Copenhagen (Denmark)
- Stage: Public
- Employee Count: 24 as on Aug 31, 2026
- Investors: Modelio Equity, Gemstone Capital and 2 Others
- Latest Funding Round: Grant (prize money), Apr 01, 2020, $*****
- Highlight: Public
_1549346657927.png?format=webp&height=120&width=120){kind=logo}
3. BROCC
Brocc is an online P2P lending platform. Investors can register with their BankID and make deposit money in their account. The platform matches investors with creditworthy borrowers. Investors receive monthly returns on investments. Borrowers can borrow up to 350,000 SEK. Charges a monthly service fee of 1.8% from both investors and borrowers.
Key facts about BROCC
- Founded Year: 2014
- Location: Stockholm (Sweden)
- Stage: Acquired
- Total Funding till date: $1.3M
- Employee Count: 61 as on May 31, 2026
- Investors: Goldman Sachs, Creades and 4 Others
- Latest Funding Round: Conventional Debt, Aug 22, 2019, $*****
- Highlight: Acquired
4. dLaboratory
Provider of power grid monitoring and analysis solutions using AI. The company offers tools for preventing outages and improving grid planning. Incident reports are automatically generated to minimize recurring issues and enhance resilience. Investment needs can be identified and prioritized based on critical issues.
Key facts about dLaboratory
- Founded Year: 2011
- Location: Lund (Sweden)
- Stage: Seed
- Total Funding till date: $1.64M
- Employee Count: 25 as on Aug 31, 2026
- Investors: Modelio Equity, Almi Invest and 5 Others
- Latest Funding Round: Seed, Nov 10, 2022, $*****
- Highlight: Editors' Pick
Qlife provides a device for blood biomarker testing. The Egoo product is a platform for biomarker testing. It measures and analyses the patient’s blood. The patient can do the testing at home themselves. It is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a feature for sharing the data with the patient’s doctor.
Key facts about Qlife Holding
- Founded Year: 2019
- Location: Helsingborg (Sweden)
- Stage: Funding Raised
- Employee Count: 26 as on May 31, 2026
- Investors: Modelio Equity and PSV Deeptech
- Highlight: Editors' Pick
Modelio Equity's Year-on-Year Investment Trends
Its most recent first time investment was in ExpreS2ion Biotechnologies.Modelio Equity's Investments by Stage
Modelio Equity has made 1 investment in Conventional Debt stage with an average round size of $815K.Modelio Equity's Investments by Sector
Modelio Equity has a diverse portfolio, with companies operating in the High Tech, Life Sciences and Sustainability Tech. Notably, it has invested in 18 Tech companies, 17 Enterprise (B2B) companies, 9 Software companies and at least 7 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
High Tech | 1 |
Life Sciences | 1 |
Sustainability Tech | 1 |
Note: We have considered here, only first round of investments
Modelio Equity's Investments by Geography
Modelio Equity has made most investments in Denmark (1).Modelio Equity's recent investments
Modelio Equity has not made any investment in 2026 so far.Here are the most recent investments by Modelio Equity:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 16, 2019 | Denmark | Conventional Debt | 3361 | - |
IPOs and Publicly Listed companies in Modelio Equity's Portfolio
4 of Modelio Equity's portfolio companies have become public. Awardit got listed on the Nordic and Baltic regions (NASDAQ OMX), in Dec 2017.Here are Modelio Equity's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 05, 2017 | - | - | 7865 | |
- | - | - | 8116 | |
- | Oct 16, 2019 | Conventional Debt | 9946 | |
- | - | - | 5332 |
Acquired companies in Modelio Equity's Portfolio
3 companies from Modelio Equity's portfolio have been acquired. The most recent acquisition was BROCC in Oct 2025 by Cerberus Capital Management for $*****.Here are Modelio Equity's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 30, 2025 | - | - | 8730 | |
Feb 18, 2021 | - | - | 5167 | |
Jun 01, 2007 | - | - | 2789 |
_1549346657927.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of Modelio Equity
Modelio Equity has a team of 5 members located in Sweden. Modelio Equity's team does not sit on the board of any company as of now.Co-investors of Modelio Equity
Over the past 7 years, 2 investors have co-invested in Modelio Equity's portfolio companies. This includes funds and angels.
- Invested before Modelio Equity: Europa has invested before Modelio Equity.
- Invested after Modelio Equity: Jenner Institute (1 company) is the only investor which has invested in Modelio Equity's portfolio after their investments.
Recent News related to Modelio Equity
•
•
•
ExpreS 2 ion Secures SEK 8 Million in Bridge Financing to Facilitate Further GrowthCMOCRO•Oct 16, 2019•ExpreS2ion Biotechnologies, Modelio Equity
